Caribou raises $30M series B

CRISPR company Caribou Biosciences Inc. (Berkeley, Calif.) raised $30 million in a series B round. New investors Anterra Capital, Heritage Group, Maverick Capital and Pontifax AgTech joined existing investors F-Prime Capital, Novartis AG (NYSE:NVS; SIX:NOVN), Mission Bay Capital and 5 Prime Ventures. Anterra's Philip Austin joined Caribou's board. ...